Swapping the serotype: A novel helper-dependent adenoviral vector platform for in vivo HSC gene therapy
Denise Klatt1, Christian Brendel1, Daniel E Bauer1
1Dana Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, USA.
Molecular Therapy. Methods & Clinical Development
|June 19, 2023
Abstract
No abstract available in PubMed .


